IL32 and rheumatoid arthritis: Overexpression of IL-32 has been reported in rheumatoid arthritis (RA) (17) and Crohn's disease (18), as well as, in human symptomatic atherosclerotic plaques (19), compared to asymptomatic individuals (20).